Galectin Therapeutics Inc. (GALT)

[Amatuer17]

This is now a binary event stock - Early Dec the topline results will be declared - they confirmed again today. It will show if drug works or not.
Also they have operational funds till Jan'18 which means dilution will come.


"This would represent a breakthrough therapeutic intervention that may prevent complications, alleviate the need for liver transplant, and even save lives. We are pleased that our Phase 2b trial in NASH cirrhosis is fully enrolled as there are other NASH clinical trials that have reported challenges meeting their original enrollment goals. Some trials have even had to modify the veracity of their clinical endpoints, all of which makes the imminent reporting of our top line results in December that much more important"